Patients with T1DM typically exhibit a distinct endocrine profile characterized by reduced serum IGF-I, increased growth hormone (GH), and elevated IGFBP-1, largely due to low hepatic insulin concentration [23,24]. This evidence concerns the gene INS and type 1 diabetes mellitus.